• Home
  • Company Information
  • Sotac Pharmaceuticals Ltd
S

Sotac Pharmaceuticals Ltd Share Price Pharmaceuticals
(%)

  • NSE
  • BSE

What is Sotac Pharmaceuticals Ltd revenue and profit growth?

  • BSE Code 78648
  • NSE Symbol SOTAC
  • ISIN Demat INE0O2D01012
  • Book Value (₹) 47.99
  • Face Value (₹) 10.00
  • Market Cap (₹ Cr.) 129.29
  • P/E (TTM) 27.15
  • EPS (TTM) 4.31
  • Div Yield (%) 0.00

Is Sotac Pharmaceuticals Ltd financially strong enough to invest in?

Today’s Low
Today’s High

52W Low
52W High

Open
Prev. Close
Volume

What corporate actions has Sotac Pharmaceuticals Ltd announced recently?

Sotac Pharmaceuticals Limited - Shareholders meeting
Oct 01, 2025

Sotac Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 29, 2025. Further, the company has informed the Exchange regarding voting results.

Sotac Pharmaceuticals Limited - Appointment
Oct 01, 2025

Sotac Pharmaceuticals Limited has informed the Exchange regarding Change in Designation of Ms. Dimpalben Dhebarbhai Patel from Additional Non- Executive Independent Director to Non- Executive Independent Director of the company w.e.f. May 24, 2025.

Sotac Pharmaceuticals Limited - Trading Window
Sep 30, 2025

Sotac Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Sotac Pharmaceuticals Limited - Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
Apr 08, 2025

Sotac Pharmaceuticals Limited has informed regarding Submission of Non-Applicability of the Regulation 27(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Sotac Pharmaceuticals Limited - Certificate under SEBI (Depositories and Participants) Regulations, 2018
Apr 08, 2025

Sotac Pharmaceuticals Limited has informed the Exchange about Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended on March 31, 2025.